Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews

In memo to then-Commissioner Califf during review of Sarepta's Exondys 51, Jenkins wrote that he was concerned about leaving OND in hands of CDER director upon his retirement.